A B56γ mutation in lung cancer disrupts the p53-dependent tumor-suppressor function of protein phosphatase 2A
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Earlier studies have shown both p53-dependent and -independent tumor-suppressive functions of B56γ-specific protein phosphatase 2A (B56γ–PP2A). In the absence of p53, B56γ–PP2A can inhibit cell proliferation and cell transformation by an unknown mechanism. In the presence of p53, on DNA damage, a complex including B56γ–PP2A and p53 is formed, which leads to Thr55 dephosphorylation of p53, induction of the p53 transcriptional target p21 and inhibition of cell proliferation. In spite of its significance in inhibition of cell proliferation, no B56γ mutations have been linked to human cancer to date. In this study, we first differentiate between the p53-dependent and -independent functions of B56γ–PP2A by identifying a domain of the B56γ protein required for interaction with p53. Within this region, we identify a B56γ mutation, F395C, in lung cancer that disrupts the B56γ–p53 interaction. More importantly, we show that F395C is unable to promote p53 Thr55 dephosphorylation, transcriptional activation of p21 and the p53-dependent tumor-suppressive function of PP2A. This finding provides a mechanistic basis for the p53-dependent and -independent functions of B56γ–PP2A and establishes a critical link between B56γ–PP2A p53-dependent tumor-suppressive function and tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Chen, W., Arroyo, J. D., Timmons, J. C., Possemato, R., & Hahn, W. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1103 · Cited by 159 · cited 2×
“Interestingly, mutational analyses of PP2A genes have yielded data suggesting PP2A Aa and Ab mutations are present in some cancers (Wang et al., 1998; Ruediger et al., 2001a, b; Chen et al., 2005; Esplin et al., 2006).”
RetractedBlinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163 · cited 2×
“…sarcoma (Grochola et al, 2009), no mutations in the B56α, B56δ and B56γ tumor suppressors have been linked to human cancer to date. p53 is a very important highly studied tumor suppressor protein that functions primarily as a transcription factor (Vousden and Prives 2009; Kruse and Gu, 2009).”
Kruse, J.-P., & Gu, W. (2009) · Cell · doi:10.1016/j.cell.2009.04.050 · Cited by 1,610 · cited 2×
“…sarcoma (Grochola et al, 2009), no mutations in the B56α, B56δ and B56γ tumor suppressors have been linked to human cancer to date. p53 is a very important highly studied tumor suppressor protein that functions primarily as a transcription factor (Vousden and Prives 2009; Kruse and Gu, 2009).”
Petitjean, A., Mathe, E., Kato, S., Ishioka, C., Tavtigian, S. V., Hainaut, P., & Olivier, M. (2007) · Human Mutation · doi:10.1002/humu.20495 · Cited by 1,598 · cited 2×
“However, recent data suggest that as many as 61% of lung tumors have wild-type p53 (Petitjean et al., 2007), suggesting the importance of the B56g3–p53 interaction in regulating wild-type p53 tumor suppression function.”
Post-translational modification of p53 in tumorigenesis
Bode, A. M., & Dong, Z. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1455 · Cited by 1,270
Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme
Cho, U. S., & Xu, W. (2007) · Nature · doi:10.1038/nature05351 · Cited by 459 · cited 5×
“These results, along with recent crystallography studies of the B56γ-PP2A complex (Cho and Xu, 2006; Xu et al., 2006), led us to focus our investigations toward identifying the region of B56γ required for interaction with p53 as an attempt to better understand its p53-dependent and –independent…”
InfluentialStructure of the Protein Phosphatase 2A Holoenzyme
Xu, Y., Xing, Y., Chen, Y., Chao, Y., Lin, Z., Fan, E., Yu, J. W., Strack, S., Jeffrey, P. D., & Shi, Y. (2006) · Cell · doi:10.1016/j.cell.2006.11.033 · Cited by 450 · cited 5×
“These results, along with recent crystallography studies of the B56γ-PP2A complex (Cho and Xu, 2006; Xu et al., 2006), led us to focus our investigations toward identifying the region of B56γ required for interaction with p53 as an attempt to better understand its p53-dependent and –independent…”
InfluentialIdentification of specific PP2A complexes involved in human cell transformation
Chen, W., Possemato, R., Campbell, K. T., Plattner, C. A., Pallas, D. C., & Hahn, W. C. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00026-1 · Cited by 325 · cited 2×
“…at Ser62 leading to its inactivation (Arnold and Sears, 2006), B56δ-PP2A (PPP2R5D) dephosphorylates Cdc25 blocking cell cycle progression (Margolis et al., 2006; Forester et al., 2007), and B56γ-PP2A (PPP2R5C) was shown to be important in SV40 mediated cell transformation (Chen et al., 2004).”
Arnold, H. K., & Sears, R. C. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.7.2832-2844.2006 · Cited by 251 · cited 2×
“It has been shown that B56a–PP2A (PPP2R5A) dephosphorylates the c-myc oncogene at Ser62, leading to its inactivation (Arnold and Sears, 2006); B56d–PP2A (PPP2R5D) dephosphorylates Cdc25, blocking cellcycle progression (Margolis et al.”
Cited by
Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer
Seshacharyulu, P., Pandey, P., Datta, K., & Batra, S. K. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.02.036 · Cited by 481
All roads lead to PP 2A: exploiting the therapeutic potential of this phosphatase
Sangodkar, J., Farrington, C. C., McClinch, K., Galsky, M. D., Kastrinsky, D. B., & Narla, G. (2016) · The FEBS Journal · doi:10.1111/febs.13573 · Cited by 312
Ruvolo, P. P. (2016) · BBA Clinical · doi:10.1016/j.bbacli.2016.08.002 · Cited by 143
Ruediger, R., Ruiz, J., & Walter, G. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05744-11 · Cited by 98
“Furthermore, a B point mutation was discovered in a human lung cancer, which is located in this p53 binding region and renders the B holoenzyme inactive in T55 dephosphorylation and p53 transcriptional activation (62).”
BackgroundMeeusen, B., & Janssens, V. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.10.002 · Cited by 96
Metadata
- Authors
- Shouse, G. P., Nobumori, Y., & Liu, X.
- Venue
- Oncogene
- Published
- 2010-05-17
- Volume
- 29
- Issue
- 27
- Pages
- 3933-3941
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2011782300
- Cited by
- 49
- References
- 9
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A B56γ mutation in lung cancer disrupts the p53-dependent tumor-suppressor function of protein phosphatase 2A. https://app.cochat.ai/papers/10.1038/onc.2010.161
- The paper
- Shouse, G. P., Nobumori, Y., & Liu, X. (2010). A B56γ mutation in lung cancer disrupts the p53-dependent tumor-suppressor function of protein phosphatase 2A. Oncogene. https://doi.org/10.1038/onc.2010.161
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.